Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Deanna Koger"'
Autor:
David M. Holtzman, Jessica L. Restivo, Kelly R. Bales, Steven M. Paul, Robert D. Kinley, Deanna Koger, Cynthia DeLong, Jesse M. Hunter, Suizhen Lin, Patrick Sullivan, Feng Liu, John R. Cirrito, Lingzhi Zhao
Publikováno v:
Brain Research. 1467:120-132
The apolipoprotein ε4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease (AD) and is associated with earlier age of onset. The incidence of spontaneous seizures has been reported to be increased in sporadic AD as well as
Autor:
B. Han, Kelly R. Bales, Feng Liu, Steven M. Paul, Su Wu, Deanna Koger, John F. Ervin, Patrick Sullivan, Brian E. Mace
Publikováno v:
Neurobiology of Aging. 32:791-801
The APOE4 allele is the most common genetic determinant for Alzheimer's disease (AD) in the developed world. APOE genotype specific differences in brain apolipoprotein E protein levels have been observed in numerous studies since the discovery of APO
Autor:
Cynthia DeLong, Steven M. Paul, Su Wu, Kelly R. Bales, Patrick Sullivan, Suizhen Lin, Deanna Koger, Feng Liu, Jeffrey C. Hansen
Publikováno v:
The Journal of Neuroscience. 29:6771-6779
To investigate the role of human apolipoprotein E (apoE) on Aβ depositionin vivo, we crossed PDAPP mice lacking mouseApoeto targeted replacement mice expressing human apoE (PDAPP/TRE2, PDAPP/TRE3, or PDAPP/TRE4). We then measured the levels of apoE
Autor:
Valentina Gelfanova, Jesse M. Hunter, Kelly R. Bales, Steven M. Paul, Suizhen Lin, Lingzhi Zhao, Feng Liu, John E. Hale, Deanna Koger, Cynthia DeLong
Publikováno v:
The Journal of Neuroscience. 29:3603-3612
Recent studies suggest that bone marrow-derived macrophages can effectively reduce β-amyloid (Aβ) deposition in brain. To further elucidate the mechanisms by which macrophages degrade Aβ, we cultured murine macrophages on top of Aβ plaque-bearing
Publikováno v:
Drug Development Research.
Recently there is increased regulatory interest in the assessment of physical dependence and withdrawal as part of the safety assessment for novel therapeutic entities. Choosing appropriate and sensitive parameters to detect withdrawal syndromes, and
Publikováno v:
Drug development research. 75(3)
Recently there is increased regulatory interest in the assessment of physical dependence and withdrawal as part of the safety assessment for novel therapeutic entities. Choosing appropriate and sensitive parameters to detect withdrawal syndromes, and
Publikováno v:
Alzheimer's & Dementia. 2
Autor:
Kumiko Takeuchi, Todd J. Kohn, Nicholas A. Honigschmidt, Vincent P. Rocco, Patrick G. Spinazze, Susan K. Hemrick-Luecke, Linda K. Thompson, David C. Evans, Kurt Rasmussen, Deanna Koger, David Lodge, Laura J. Martin, Janice Shaw, Penny G. Threlkeld, David T. Wong
Publikováno v:
Bioorganicmedicinal chemistry letters. 16(9)
A series of 1-aryloxy-3-piperidinylpropan-2-ols possessing potent dual 5-HT1A receptor antagonism and serotonin reuptake inhibition was discovered. 1-(1H-Indol-4-yloxy)-3-(4-benzo[b]thiophen-2-ylpiperidinyl)propan-2-ols exhibited selective and high a
Autor:
Steven M. Paul, Michail A. Esterman, Jeffrey C. Hanson, Xin Wu, Kelly R. Bales, Seema Malkani, Milla Koistinaho, Suizhen Lin, Feng Liu, Richard E. Higgs, Deanna Koger
Publikováno v:
Nature medicine. 10(7)
We have previously shown that apolipoprotein E (Apoe) promotes the formation of amyloid in brain and that astrocyte-specific expression of APOE markedly affects the deposition of amyloid-beta peptides (Abeta) in a mouse model of Alzheimer disease. Gi
Autor:
Su Wu, Cindy A. DeLong, J. Dorocke, Ronald Demattos, U. Kuchibhotla, V. Wroblewski, K.R. Bales, Margaret M. Racke, J. Lu, Deanna Koger
Publikováno v:
Neurobiology of Aging. 25:S587